Rx Medicare

Funxional Therapeutics Ltd (Funxional) has announced the successful completion of the first Phase I study with FX125L, an orally available small molecule which belongs to a new therapeutic class named Broad Spectrum Chemokine Inhibitors (BSCIs). The Phase I, single ascending dose study was conducted in the United States. FX125L was well tolerated at all doses studied and no serious adverse events or subject withdrawals were observed.

Read More…

Related Posts

• Zogenix Initiates Pivotal Phase 3 Clinical Trial For Novel Formulation Of Oral Controlled-Release Hydrocodone
• China Aoxing Pharmaceutical Company Announces Successful Completion Of Phase II Clinical Study Of Novel Menstrual Pain Drug
• Biostar Pharmaceuticals, Inc. Receives The Chinese Military Drug Administration Clearance To Begin Clinical Trial For Zushima Analgesic Aerosol Spray
• Prozac and Celexa exhibit anti-inflammatory effects
• PositiveID Corporation Successfully Completes Phase I Development Of Its Rapid Virus Detection System
• Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit In Preventing Influenza-Like Illness In Seniors
• Clinical Trial: Miniature Ultrasound Device Could Revolutionize Pain Relief
• Trigemina Conducting Phase IIa Clinical Trial In Chronic Daily Headache
• Toward A Less Expensive Version Of The Anti-flu Drug Tamiflu
• Painkiller undermines aspirin’s anti-clotting action
• CNSBio Inc. To Present Latest Clinical Trial Data For CNSB015 At Neuropathic Pain Conference In San Francisco
• Winston Laboratories, Inc. Announces Positive Top-line Results Of Phase II Clinical Trial Of Civamide Patch
• NanoViricides, Inc. To Present Anti-Influenza Drug Candidate FluCide™ Studies At The Influenza Congress 2009
• Key Mechanism In Brain Development Pinpointed, Raising Question About Use Of Antiseizure Drug
• Study Pinpoints Key Mechanism In Brain Development, Raising Question About Use Of Antiseizure Drug

Tags: action, anti, clinical, completes, drug, funxional, fx125l, inflammatory, initial, mechanism, novel, successfully, trial

This entry was posted on Friday, July 10th, 2009 at 1:07 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.